Issue: Exclusive Online Content, Posted Date: 12/22/2016

Cartridge Filling: Combination Features That Can Help Gain a Competitive Edge

 

 


By 2050, it is projected that the proportion of people aged 65 and older will be more than double that of children aged 5. This global phenomenon is also leading to an increasing number of people suffering from chronic diseases, such as diabetes and osteoporosis. Combined, these trends are making it difficult for healthcare professionals to effectively treat patients over the long-term. Thus, increased attention is leading to a growth in patient-friendly administration systems, such as single-and dual-chamber cartridges in combination with a pen device.

 

Cartridge Systems Offer a Competitive Advantage

 

For pharmaceutical and biotech companies looking to gain a competitive edge, pen injectors and cartridges offer an attractive alternative to vials because their combination of features offer advanced design, product differentiation, and improved life cycle management. There are a number of drivers for a cartridge-pen combination approach to drug administration, including a growing concern for patient safety, compliance, and consistency, an increasing need for self-medication in the home - particularly for chronic diseases, and a preference for differentiation.

 

What are the Challenges of Cartridge Systems?

 

Along with the many advantages cartridge systems offer, there are challenges to be considered as development of a cartridge-pen combination can be complex. Such systems are essentially devices that are a combination product. As such, they bring together a number of elements, including a drug and a device, a device and a biological product, a biological product and a drug, or a device and a biological product. The challenges of such systems include:

 

Regulatory DemandsCombination products are subject to specific FDA regulations related to their constituent parts, which means the components must be addressed individually. Human factor and clinical study considerations must also be taken into account for combination products.

 

cGMP requirements – GMP guidance for such products must be followed. And, as with regulatory demands, cGMP requirements apply to all constituent parts.

 

The Choice of Partner is Essential for Success

 

When the choice is a cartridge system, partnering with a leader experienced in developing combination products can be invaluable when navigating the special regulatory processes. Along with regulatory know-how, the following criteria should be considered when selecting a partner:

 

- A successful track record in cartridge development

- Capabilities in manufacturing processes

- Capabilities in cartridge filling – clinical and commercial

- Selection of packaging materials

 

Also consider that because cartridges require a filling and pen assembly solution, a single point of contact can help simplify accountability and response from your partner.

 

For more information about cartridge-pen combinations, please follow this link:

Cartridge filling: Understanding the complexities or visit www.vetter-pharma.com.


Related Taxonomy
Popularity:
This record has been viewed 1135 times.



















- SHL


Click here to see the showcases


RDD (Respiratory Drug Delivery)
April 25-28
Nice, France

Pre-filled Syringes East Coast
April 26-27
Boston, MA


AAPS National Biotechnology Meeting
May 1-3
San Diego, CA

Innovation Networking Summit & Table-top Exhibition
May 4-5
Hilton Hotel, Parsippany, NJ

CPhI North America & Informex
May 16-18
2017 Philadelphia, PA

Pre-filled Syringes West Coast
June 5th & 6th, San Diego, USA

BIO 2017

June 19 - 22
San Diego, CA

Controlled Release Society Meeting
July 16-19 Boston, MA

CPhI Worldwide
October 24-26
Frankfurt, Germany

Universe of Prefilled Syringes & Injection Devices Europe
November 7-8
Nienna, Austria

AAPS
November 12-17
San Diego, CA

 



Copyright © 2017  Drug Development & Delivery All Rights Reserved. Privacy Policy / Terms and Conditions